Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
HIV infection and COVID-19: risk factors for severe disease
Nicolas Etienne1,2, Marina Karmochkine1, Laurence Slama1
1Department of Immunology and Infectious Diseases, Cochin-Hôtel-Dieu Hospital, Assistance Publique -Hôpitaux de Paris (APHP), Hôpitaux Universitaires Paris Centre - Université de Paris.
Insights
This study found that older age, male sex, African ethnicity, and metabolic disorders increased the risk of severe COVID-19 in people living with HIV (PLWH). Antiretroviral therapy did not show a protective effect against severe COVID-19 outcomes.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- Observational prospective study on COVID-19 outcomes in people living with HIV (PLWH).
- Assessed severity and critical illness rates in 54 PLWH diagnosed with COVID-19.
- Identified risk factors associated with severe or critical COVID-19 in this population.
Discussion:
- Multivariate analysis revealed significant associations between severe/critical COVID-19 and age, male sex, sub-Saharan African origin, and metabolic disorders.
- No significant difference in prior CD4 T cell counts was observed between severity groups.
- Certain antiretroviral therapy classes did not confer a protective effect against severe COVID-19.
Key Insights:
- Specific demographic and clinical factors predict severe COVID-19 in PLWH.
- CD4 T cell count is not a differentiator for COVID-19 severity in this cohort.
- Current antiretroviral treatments do not appear to mitigate severe COVID-19 risk.
Outlook:
- Further research needed to understand the mechanisms behind identified risk factors.
- Investigate potential targeted interventions for high-risk PLWH subgroups.
- Explore novel therapeutic strategies for managing COVID-19 in immunocompromised populations.
Abstract:
: We performed an observational prospective monocentric study in patients living with HIV (PLWH) diagnosed with COVID-19. Fifty-four PLWH developed COVID-19 with 14 severe (25.9%) and five critical cases (9.3%), respectively. By multivariate analysis, age, male sex, ethnic origin from sub-Saharan Africa and metabolic disorder were associated with severe or critical forms of COVID-19. Prior CD4 T cell counts did not differ between groups. No protective effect of a particular antiretroviral class was observed.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

